Preload Image
Preload Image
Report Store mobile icon
Global Vascular Stents Market Growth 2024-2030

Global Vascular Stents Market Growth 2024-2030

2024

Global Vascular Stents Market Growth 2024-2030

The Vascular Stents market, valued at US$ 15,510 million in 2024, is expanding with rising demand for advanced stents in the treatment of cardiovascular diseases.

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global vascular stents market has experienced substantial growth, driven by the rising prevalence of cardiovascular diseases and advancements in medical technology. Vascular stents are small, tubular devices that are used to open narrowed or blocked blood vessels, particularly in cases of atherosclerosis, coronary artery disease, and peripheral artery disease. These devices are crucial in treating conditions that hinder blood flow, allowing patients to maintain proper circulation. The increasing prevalence of lifestyle-related diseases, such as obesity, hypertension, and diabetes, which are known risk factors for vascular diseases, has significantly contributed to the growing demand for vascular stents. Additionally, the market is fueled by the continuous development of advanced stent technologies, including drug-eluting stents (DES), biodegradable stents, and self-expanding stents, which offer enhanced performance and reduce the risk of complications. The use of these innovative stents has helped improve patient outcomes and reduce the incidence of restenosis, a common complication associated with traditional stents. As the healthcare industry embraces technological innovations and the global population ages, the demand for vascular stents is expected to increase, further driving the market growth. Furthermore, rising awareness regarding the benefits of stent procedures, coupled with advancements in minimally invasive techniques, such as angioplasty, has expanded the adoption of vascular stents across hospitals and healthcare facilities worldwide. With the increasing number of procedures performed annually, the vascular stents market is set to grow significantly, providing new opportunities for market players and healthcare providers alike.

According to Publisher, the global Vascular Stents market size was valued at US$ 15510 million in 2024. With growing demand in downstream market, the Vascular Stents is forecast to a readjusted size of US$ 23030 million by 2030 with a CAGR of 5.8% during review period. North America currently holds a significant share of the global vascular stents market, primarily due to the high incidence of cardiovascular diseases and the presence of advanced healthcare infrastructure. The United States, in particular, represents a major market for vascular stents, with a well-established healthcare system and significant investments in cardiovascular research and treatment. The rising aging population in this region is a key factor contributing to the demand for vascular stents, as elderly individuals are more prone to developing cardiovascular diseases. Additionally, the growing adoption of minimally invasive procedures, such as percutaneous coronary interventions (PCI), has driven the usage of stents for the treatment of coronary artery disease. Europe follows closely, with countries like Germany, France, and the United Kingdom demonstrating strong demand for vascular stents. The European market is characterized by a high standard of healthcare and an increasing number of patients opting for advanced stenting techniques. Asia Pacific is witnessing rapid growth in the vascular stents market, driven by the rising healthcare expenditure and the increasing prevalence of cardiovascular diseases in countries such as China, India, and Japan. The growing healthcare infrastructure in these nations, coupled with improved access to advanced medical treatments, is significantly contributing to the expansion of the market. Emerging economies in Latin America and the Middle East are also expected to see steady growth in the adoption of vascular stents due to improving healthcare facilities and increasing awareness of cardiovascular health. As the demand for stent procedures rises across these regions, the global vascular stents market is projected to continue its upward trajectory, with technological innovations and growing healthcare investments playing a pivotal role in shaping the market's future.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


The vascular stents market is segmented based on types, with drug-eluting stents (DES), bare-metal stents (BMS), bioresorbable stents, and self-expanding stents being the most widely used variants. Drug-eluting stents are the most preferred option due to their ability to release medication gradually to prevent restenosis and reduce the need for additional procedures. These stents have gained widespread acceptance for their effectiveness in improving patient outcomes, particularly in high-risk patients who are prone to restenosis. The bare-metal stents, while being more affordable, are used less frequently compared to drug-eluting stents because they are associated with a higher risk of restenosis. However, bare-metal stents are still commonly used in patients who cannot tolerate the drugs used in drug-eluting stents or who require a quick and cost-effective solution. Bioresorbable stents are an emerging innovation in the vascular stents market, offering the advantage of being completely absorbed by the body over time. This eliminates the need for long-term stent maintenance and the risk of complications associated with permanent stents. These stents are particularly beneficial for young patients or those requiring stent placement in sensitive areas. Self-expanding stents, typically used for peripheral artery disease, are designed to expand automatically once deployed, making them ideal for treating narrow or tortuous vessels. The choice of stent type depends largely on the patient's condition, the location of the blockage, and the potential for future complications. As stent technology continues to evolve, new variations and improvements are expected to enhance the market’s growth, providing more customized and effective treatment options for patients suffering from vascular diseases.

The vascular stents market is also segmented by application, with the most significant demand arising from the coronary artery disease (CAD) and peripheral artery disease (PAD) segments. Coronary artery disease, characterized by the buildup of plaque in the coronary arteries, is one of the leading causes of heart attacks and is the most common reason for the use of vascular stents. Stenting procedures such as percutaneous coronary interventions (PCI) are frequently used to treat CAD by restoring blood flow to the heart, which can reduce the risk of heart attacks and other cardiovascular complications. The growing prevalence of CAD, fueled by lifestyle factors such as poor diet, lack of exercise, and smoking, has led to an increased demand for coronary stenting procedures. Additionally, the rising aging population, who are more prone to CAD, further contributes to the demand for vascular stents in treating coronary artery blockages. Peripheral artery disease, which occurs when there is a narrowing of the peripheral arteries, often leads to pain and difficulty walking due to inadequate blood flow to the limbs. The treatment of PAD typically involves stenting to open blocked arteries, particularly in the legs. As the number of patients with PAD continues to rise, driven by factors such as diabetes and smoking, the demand for stents in treating peripheral artery blockages is also expected to increase. Other applications, such as renal artery disease and carotid artery disease, are also important segments in the vascular stents market, although they represent a smaller portion of the overall market. The continual growth in the number of procedures performed for CAD and PAD, along with the increasing effectiveness of stenting treatments, ensures that vascular stents will remain an essential part of modern cardiovascular care. The increasing awareness of vascular health and the adoption of advanced stenting technologies will likely drive market growth in these applications, helping to address the global burden of vascular diseases.


Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Vascular Stents Annual Sales 2019-2030
  • 2.1.2 World Current & Future Analysis for Vascular Stents by Geographic Region, 2019, 2023 & 2030
  • 2.1.3 World Current & Future Analysis for Vascular Stents by Country/Region, 2019, 2023 & 2030
  • 2.2 Vascular Stents Segment by Type
  • 2.2.1 Bare-Metal Stents
  • 2.2.2 Drug-Eluting Stents
  • 2.2.3 Bioabsorbable Stents
  • 2.3 Vascular Stents Sales by Type
  • 2.3.1 Global Vascular Stents Sales Market Share by Type (2019-2024)
  • 2.3.2 Global Vascular Stents Revenue and Market Share by Type (2019-2024)
  • 2.3.3 Global Vascular Stents Sale Price by Type (2019-2024)
  • 2.4 Vascular Stents Segment by Application
  • 2.4.1 Hospitals & Cardiac Centers
  • 2.4.2 Ambulatory Surgical Centers
  • 2.5 Vascular Stents Sales by Application
  • 2.5.1 Global Vascular Stents Sale Market Share by Application (2019-2024)
  • 2.5.2 Global Vascular Stents Revenue and Market Share by Application (2019-2024)
  • 2.5.3 Global Vascular Stents Sale Price by Application (2019-2024)
  • 3 Global Vascular Stents by Company
  • 3.1 Global Vascular Stents Breakdown Data by Company
  • 3.1.1 Global Vascular Stents Annual Sales by Company (2019-2024)
  • 3.1.2 Global Vascular Stents Sales Market Share by Company (2019-2024)
  • 3.2 Global Vascular Stents Annual Revenue by Company (2019-2024)
  • 3.2.1 Global Vascular Stents Revenue by Company (2019-2024)
  • 3.2.2 Global Vascular Stents Revenue Market Share by Company (2019-2024)
  • 3.3 Global Vascular Stents Sale Price by Company
  • 3.4 Key Manufacturers Vascular Stents Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Vascular Stents Product Location Distribution
  • 3.4.2 Players Vascular Stents Products Offered
  • 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Vascular Stents by Geographic Region
  • 4.1 World Historic Vascular Stents Market Size by Geographic Region (2019-2024)
  • 4.1.1 Global Vascular Stents Annual Sales by Geographic Region (2019-2024)
  • 4.1.2 Global Vascular Stents Annual Revenue by Geographic Region (2019-2024)
  • 4.2 World Historic Vascular Stents Market Size by Country/Region (2019-2024)
  • 4.2.1 Global Vascular Stents Annual Sales by Country/Region (2019-2024)
  • 4.2.2 Global Vascular Stents Annual Revenue by Country/Region (2019-2024)
  • 4.3 Americas Vascular Stents Sales Growth
  • 4.4 APAC Vascular Stents Sales Growth
  • 4.5 Europe Vascular Stents Sales Growth
  • 4.6 Middle East & Africa Vascular Stents Sales Growth
  • 5 Americas
  • 5.1 Americas Vascular Stents Sales by Country
  • 5.1.1 Americas Vascular Stents Sales by Country (2019-2024)
  • 5.1.2 Americas Vascular Stents Revenue by Country (2019-2024)
  • 5.2 Americas Vascular Stents Sales by Type
  • 5.3 Americas Vascular Stents Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Vascular Stents Sales by Region
  • 6.1.1 APAC Vascular Stents Sales by Region (2019-2024)
  • 6.1.2 APAC Vascular Stents Revenue by Region (2019-2024)
  • 6.2 APAC Vascular Stents Sales by Type
  • 6.3 APAC Vascular Stents Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan
  • 7 Europe
  • 7.1 Europe Vascular Stents by Country
  • 7.1.1 Europe Vascular Stents Sales by Country (2019-2024)
  • 7.1.2 Europe Vascular Stents Revenue by Country (2019-2024)
  • 7.2 Europe Vascular Stents Sales by Type
  • 7.3 Europe Vascular Stents Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Vascular Stents by Country
  • 8.1.1 Middle East & Africa Vascular Stents Sales by Country (2019-2024)
  • 8.1.2 Middle East & Africa Vascular Stents Revenue by Country (2019-2024)
  • 8.2 Middle East & Africa Vascular Stents Sales by Type
  • 8.3 Middle East & Africa Vascular Stents Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis
  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Vascular Stents
  • 10.3 Manufacturing Process Analysis of Vascular Stents
  • 10.4 Industry Chain Structure of Vascular Stents
  • 11 Marketing, Distributors and Customer
  • 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
  • 11.2 Vascular Stents Distributors
  • 11.3 Vascular Stents Customer
  • 12 World Forecast Review for Vascular Stents by Geographic Region
  • 12.1 Global Vascular Stents Market Size Forecast by Region
  • 12.1.1 Global Vascular Stents Forecast by Region (2025-2030)
  • 12.1.2 Global Vascular Stents Annual Revenue Forecast by Region (2025-2030)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Vascular Stents Forecast by Type
  • 12.7 Global Vascular Stents Forecast by Application
  • 13 Key Players Analysis
  • 13.1 Medtronic Plc
  • 13.1.1 Medtronic Plc Company Information
  • 13.1.2 Medtronic Plc Vascular Stents Product Portfolios and Specifications
  • 13.1.3 Medtronic Plc Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.1.4 Medtronic Plc Main Business Overview
  • 13.1.5 Medtronic Plc Latest Developments
  • 13.2 Abbott Laboratories
  • 13.2.1 Abbott Laboratories Company Information
  • 13.2.2 Abbott Laboratories Vascular Stents Product Portfolios and Specifications
  • 13.2.3 Abbott Laboratories Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.2.4 Abbott Laboratories Main Business Overview
  • 13.2.5 Abbott Laboratories Latest Developments
  • 13.3 Boston Scientific Corporation
  • 13.3.1 Boston Scientific Corporation Company Information
  • 13.3.2 Boston Scientific Corporation Vascular Stents Product Portfolios and Specifications
  • 13.3.3 Boston Scientific Corporation Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.3.4 Boston Scientific Corporation Main Business Overview
  • 13.3.5 Boston Scientific Corporation Latest Developments
  • 13.4 Biotronik Se & Co. Kg
  • 13.4.1 Biotronik Se & Co. Kg Company Information
  • 13.4.2 Biotronik Se & Co. Kg Vascular Stents Product Portfolios and Specifications
  • 13.4.3 Biotronik Se & Co. Kg Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.4.4 Biotronik Se & Co. Kg Main Business Overview
  • 13.4.5 Biotronik Se & Co. Kg Latest Developments
  • 13.5 B. Braun Melsungen Ag
  • 13.5.1 B. Braun Melsungen Ag Company Information
  • 13.5.2 B. Braun Melsungen Ag Vascular Stents Product Portfolios and Specifications
  • 13.5.3 B. Braun Melsungen Ag Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.5.4 B. Braun Melsungen Ag Main Business Overview
  • 13.5.5 B. Braun Melsungen Ag Latest Developments
  • 13.6 Terumo Corporation
  • 13.6.1 Terumo Corporation Company Information
  • 13.6.2 Terumo Corporation Vascular Stents Product Portfolios and Specifications
  • 13.6.3 Terumo Corporation Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.6.4 Terumo Corporation Main Business Overview
  • 13.6.5 Terumo Corporation Latest Developments
  • 13.7 Microport Scientific Corporation
  • 13.7.1 Microport Scientific Corporation Company Information
  • 13.7.2 Microport Scientific Corporation Vascular Stents Product Portfolios and Specifications
  • 13.7.3 Microport Scientific Corporation Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.7.4 Microport Scientific Corporation Main Business Overview
  • 13.7.5 Microport Scientific Corporation Latest Developments
  • 13.8 Meril Life Sciences Pvt. Ltd.
  • 13.8.1 Meril Life Sciences Pvt. Ltd. Company Information
  • 13.8.2 Meril Life Sciences Pvt. Ltd. Vascular Stents Product Portfolios and Specifications
  • 13.8.3 Meril Life Sciences Pvt. Ltd. Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.8.4 Meril Life Sciences Pvt. Ltd. Main Business Overview
  • 13.8.5 Meril Life Sciences Pvt. Ltd. Latest Developments
  • 13.9 Vascular Concepts Limited
  • 13.9.1 Vascular Concepts Limited Company Information
  • 13.9.2 Vascular Concepts Limited Vascular Stents Product Portfolios and Specifications
  • 13.9.3 Vascular Concepts Limited Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.9.4 Vascular Concepts Limited Main Business Overview
  • 13.9.5 Vascular Concepts Limited Latest Developments
  • 13.10 C.R. Bard, Inc.
  • 13.10.1 C.R. Bard, Inc. Company Information
  • 13.10.2 C.R. Bard, Inc. Vascular Stents Product Portfolios and Specifications
  • 13.10.3 C.R. Bard, Inc. Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.10.4 C.R. Bard, Inc. Main Business Overview
  • 13.10.5 C.R. Bard, Inc. Latest Developments
  • 13.11 W.L. Gore and Associates, Inc.
  • 13.11.1 W.L. Gore and Associates, Inc. Company Information
  • 13.11.2 W.L. Gore and Associates, Inc. Vascular Stents Product Portfolios and Specifications
  • 13.11.3 W.L. Gore and Associates, Inc. Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.11.4 W.L. Gore and Associates, Inc. Main Business Overview
  • 13.11.5 W.L. Gore and Associates, Inc. Latest Developments
  • 13.12 Endologix, Inc.
  • 13.12.1 Endologix, Inc. Company Information
  • 13.12.2 Endologix, Inc. Vascular Stents Product Portfolios and Specifications
  • 13.12.3 Endologix, Inc. Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.12.4 Endologix, Inc. Main Business Overview
  • 13.12.5 Endologix, Inc. Latest Developments
  • 13.13 Lombard Medical
  • 13.13.1 Lombard Medical Company Information
  • 13.13.2 Lombard Medical Vascular Stents Product Portfolios and Specifications
  • 13.13.3 Lombard Medical Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.13.4 Lombard Medical Main Business Overview
  • 13.13.5 Lombard Medical Latest Developments
  • 13.14 Translumina Gmbh
  • 13.14.1 Translumina Gmbh Company Information
  • 13.14.2 Translumina Gmbh Vascular Stents Product Portfolios and Specifications
  • 13.14.3 Translumina Gmbh Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.14.4 Translumina Gmbh Main Business Overview
  • 13.14.5 Translumina Gmbh Latest Developments
  • 13.15 Jotec Gmbh
  • 13.15.1 Jotec Gmbh Company Information
  • 13.15.2 Jotec Gmbh Vascular Stents Product Portfolios and Specifications
  • 13.15.3 Jotec Gmbh Vascular Stents Sales, Revenue, Price and Gross Margin (2019-2024)
  • 13.15.4 Jotec Gmbh Main Business Overview
  • 13.15.5 Jotec Gmbh Latest Developments
  • 14 Research Findings and Conclusion


Table 1. Vascular Stents Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vascular Stents Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bare-Metal Stents
Table 4. Major Players of Drug-Eluting Stents
Table 5. Major Players of Bioabsorbable Stents
Table 6. Global Vascular Stents Sales by Type (2019-2024) & (K Units)
Table 7. Global Vascular Stents Sales Market Share by Type (2019-2024)
Table 8. Global Vascular Stents Revenue by Type (2019-2024) & ($ million)
Table 9. Global Vascular Stents Revenue Market Share by Type (2019-2024)
Table 10. Global Vascular Stents Sale Price by Type (2019-2024) & (USD/Unit)
Table 11. Global Vascular Stents Sales by Application (2019-2024) & (K Units)
Table 12. Global Vascular Stents Sales Market Share by Application (2019-2024)
Table 13. Global Vascular Stents Revenue by Application (2019-2024)
Table 14. Global Vascular Stents Revenue Market Share by Application (2019-2024)
Table 15. Global Vascular Stents Sale Price by Application (2019-2024) & (USD/Unit)
Table 16. Global Vascular Stents Sales by Company (2019-2024) & (K Units)
Table 17. Global Vascular Stents Sales Market Share by Company (2019-2024)
Table 18. Global Vascular Stents Revenue by Company (2019-2024) ($ Millions)
Table 19. Global Vascular Stents Revenue Market Share by Company (2019-2024)
Table 20. Global Vascular Stents Sale Price by Company (2019-2024) & (USD/Unit)
Table 21. Key Manufacturers Vascular Stents Producing Area Distribution and Sales Area
Table 22. Players Vascular Stents Products Offered
Table 23. Vascular Stents Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Vascular Stents Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Vascular Stents Sales Market Share Geographic Region (2019-2024)
Table 28. Global Vascular Stents Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Vascular Stents Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Vascular Stents Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Vascular Stents Sales Market Share by Country/Region (2019-2024)
Table 32. Global Vascular Stents Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Vascular Stents Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Vascular Stents Sales by Country (2019-2024) & (K Units)
Table 35. Americas Vascular Stents Sales Market Share by Country (2019-2024)
Table 36. Americas Vascular Stents Revenue by Country (2019-2024) & ($ Millions)
Table 37. Americas Vascular Stents Revenue Market Share by Country (2019-2024)
Table 38. Americas Vascular Stents Sales by Type (2019-2024) & (K Units)
Table 39. Americas Vascular Stents Sales by Application (2019-2024) & (K Units)
Table 40. APAC Vascular Stents Sales by Region (2019-2024) & (K Units)
Table 41. APAC Vascular Stents Sales Market Share by Region (2019-2024)
Table 42. APAC Vascular Stents Revenue by Region (2019-2024) & ($ Millions)
Table 43. APAC Vascular Stents Revenue Market Share by Region (2019-2024)
Table 44. APAC Vascular Stents Sales by Type (2019-2024) & (K Units)
Table 45. APAC Vascular Stents Sales by Application (2019-2024) & (K Units)
Table 46. Europe Vascular Stents Sales by Country (2019-2024) & (K Units)
Table 47. Europe Vascular Stents Sales Market Share by Country (2019-2024)
Table 48. Europe Vascular Stents Revenue by Country (2019-2024) & ($ Millions)
Table 49. Europe Vascular Stents Revenue Market Share by Country (2019-2024)
Table 50. Europe Vascular Stents Sales by Type (2019-2024) & (K Units)
Table 51. Europe Vascular Stents Sales by Application (2019-2024) & (K Units)
Table 52. Middle East & Africa Vascular Stents Sales by Country (2019-2024) & (K Units)
Table 53. Middle East & Africa Vascular Stents Sales Market Share by Country (2019-2024)
Table 54. Middle East & Africa Vascular Stents Revenue by Country (2019-2024) & ($ Millions)
Table 55. Middle East & Africa Vascular Stents Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa Vascular Stents Sales by Type (2019-2024) & (K Units)
Table 57. Middle East & Africa Vascular Stents Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Vascular Stents
Table 59. Key Market Challenges & Risks of Vascular Stents
Table 60. Key Industry Trends of Vascular Stents
Table 61. Vascular Stents Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Vascular Stents Distributors List
Table 64. Vascular Stents Customer List
Table 65. Global Vascular Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 66. Global Vascular Stents Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Americas Vascular Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Americas Vascular Stents Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. APAC Vascular Stents Sales Forecast by Region (2025-2030) & (K Units)
Table 70. APAC Vascular Stents Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Europe Vascular Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Europe Vascular Stents Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa Vascular Stents Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa Vascular Stents Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Global Vascular Stents Sales Forecast by Type (2025-2030) & (K Units)
Table 76. Global Vascular Stents Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 77. Global Vascular Stents Sales Forecast by Application (2025-2030) & (K Units)
Table 78. Global Vascular Stents Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 79. Medtronic Plc Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Plc Vascular Stents Product Portfolios and Specifications
Table 81. Medtronic Plc Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Medtronic Plc Main Business
Table 83. Medtronic Plc Latest Developments
Table 84. Abbott Laboratories Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott Laboratories Vascular Stents Product Portfolios and Specifications
Table 86. Abbott Laboratories Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Abbott Laboratories Main Business
Table 88. Abbott Laboratories Latest Developments
Table 89. Boston Scientific Corporation Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Corporation Vascular Stents Product Portfolios and Specifications
Table 91. Boston Scientific Corporation Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Boston Scientific Corporation Main Business
Table 93. Boston Scientific Corporation Latest Developments
Table 94. Biotronik Se & Co. Kg Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 95. Biotronik Se & Co. Kg Vascular Stents Product Portfolios and Specifications
Table 96. Biotronik Se & Co. Kg Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Biotronik Se & Co. Kg Main Business
Table 98. Biotronik Se & Co. Kg Latest Developments
Table 99. B. Braun Melsungen Ag Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 100. B. Braun Melsungen Ag Vascular Stents Product Portfolios and Specifications
Table 101. B. Braun Melsungen Ag Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. B. Braun Melsungen Ag Main Business
Table 103. B. Braun Melsungen Ag Latest Developments
Table 104. Terumo Corporation Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 105. Terumo Corporation Vascular Stents Product Portfolios and Specifications
Table 106. Terumo Corporation Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Terumo Corporation Main Business
Table 108. Terumo Corporation Latest Developments
Table 109. Microport Scientific Corporation Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 110. Microport Scientific Corporation Vascular Stents Product Portfolios and Specifications
Table 111. Microport Scientific Corporation Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Microport Scientific Corporation Main Business
Table 113. Microport Scientific Corporation Latest Developments
Table 114. Meril Life Sciences Pvt. Ltd. Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 115. Meril Life Sciences Pvt. Ltd. Vascular Stents Product Portfolios and Specifications
Table 116. Meril Life Sciences Pvt. Ltd. Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Meril Life Sciences Pvt. Ltd. Main Business
Table 118. Meril Life Sciences Pvt. Ltd. Latest Developments
Table 119. Vascular Concepts Limited Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 120. Vascular Concepts Limited Vascular Stents Product Portfolios and Specifications
Table 121. Vascular Concepts Limited Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Vascular Concepts Limited Main Business
Table 123. Vascular Concepts Limited Latest Developments
Table 124. C.R. Bard, Inc. Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 125. C.R. Bard, Inc. Vascular Stents Product Portfolios and Specifications
Table 126. C.R. Bard, Inc. Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. C.R. Bard, Inc. Main Business
Table 128. C.R. Bard, Inc. Latest Developments
Table 129. W.L. Gore and Associates, Inc. Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 130. W.L. Gore and Associates, Inc. Vascular Stents Product Portfolios and Specifications
Table 131. W.L. Gore and Associates, Inc. Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. W.L. Gore and Associates, Inc. Main Business
Table 133. W.L. Gore and Associates, Inc. Latest Developments
Table 134. Endologix, Inc. Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 135. Endologix, Inc. Vascular Stents Product Portfolios and Specifications
Table 136. Endologix, Inc. Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Endologix, Inc. Main Business
Table 138. Endologix, Inc. Latest Developments
Table 139. Lombard Medical Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 140. Lombard Medical Vascular Stents Product Portfolios and Specifications
Table 141. Lombard Medical Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 142. Lombard Medical Main Business
Table 143. Lombard Medical Latest Developments
Table 144. Translumina Gmbh Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 145. Translumina Gmbh Vascular Stents Product Portfolios and Specifications
Table 146. Translumina Gmbh Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 147. Translumina Gmbh Main Business
Table 148. Translumina Gmbh Latest Developments
Table 149. Jotec Gmbh Basic Information, Vascular Stents Manufacturing Base, Sales Area and Its Competitors
Table 150. Jotec Gmbh Vascular Stents Product Portfolios and Specifications
Table 151. Jotec Gmbh Vascular Stents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 152. Jotec Gmbh Main Business
Table 153. Jotec Gmbh Latest Developments
List of


Figure 1. Picture of Vascular Stents
Figure 2. Vascular Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Stents Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Vascular Stents Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Vascular Stents Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Bare-Metal Stents
Figure 10. Product Picture of Drug-Eluting Stents
Figure 11. Product Picture of Bioabsorbable Stents
Figure 12. Global Vascular Stents Sales Market Share by Type in 2023
Figure 13. Global Vascular Stents Revenue Market Share by Type (2019-2024)
Figure 14. Vascular Stents Consumed in Hospitals & Cardiac Centers
Figure 15. Global Vascular Stents Market: Hospitals & Cardiac Centers (2019-2024) & (K Units)
Figure 16. Vascular Stents Consumed in Ambulatory Surgical Centers
Figure 17. Global Vascular Stents Market: Ambulatory Surgical Centers (2019-2024) & (K Units)
Figure 18. Global Vascular Stents Sales Market Share by Application (2023)
Figure 19. Global Vascular Stents Revenue Market Share by Application in 2023
Figure 20. Vascular Stents Sales Market by Company in 2023 (K Units)
Figure 21. Global Vascular Stents Sales Market Share by Company in 2023
Figure 22. Vascular Stents Revenue Market by Company in 2023 ($ Million)
Figure 23. Global Vascular Stents Revenue Market Share by Company in 2023
Figure 24. Global Vascular Stents Sales Market Share by Geographic Region (2019-2024)
Figure 25. Global Vascular Stents Revenue Market Share by Geographic Region in 2023
Figure 26. Americas Vascular Stents Sales 2019-2024 (K Units)
Figure 27. Americas Vascular Stents Revenue 2019-2024 ($ Millions)
Figure 28. APAC Vascular Stents Sales 2019-2024 (K Units)
Figure 29. APAC Vascular Stents Revenue 2019-2024 ($ Millions)
Figure 30. Europe Vascular Stents Sales 2019-2024 (K Units)
Figure 31. Europe Vascular Stents Revenue 2019-2024 ($ Millions)
Figure 32. Middle East & Africa Vascular Stents Sales 2019-2024 (K Units)
Figure 33. Middle East & Africa Vascular Stents Revenue 2019-2024 ($ Millions)
Figure 34. Americas Vascular Stents Sales Market Share by Country in 2023
Figure 35. Americas Vascular Stents Revenue Market Share by Country in 2023
Figure 36. Americas Vascular Stents Sales Market Share by Type (2019-2024)
Figure 37. Americas Vascular Stents Sales Market Share by Application (2019-2024)
Figure 38. United States Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 39. Canada Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 40. Mexico Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 41. Brazil Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 42. APAC Vascular Stents Sales Market Share by Region in 2023
Figure 43. APAC Vascular Stents Revenue Market Share by Regions in 2023
Figure 44. APAC Vascular Stents Sales Market Share by Type (2019-2024)
Figure 45. APAC Vascular Stents Sales Market Share by Application (2019-2024)
Figure 46. China Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 47. Japan Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 48. South Korea Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 49. Southeast Asia Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 50. India Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 51. Australia Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 52. China Taiwan Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 53. Europe Vascular Stents Sales Market Share by Country in 2023
Figure 54. Europe Vascular Stents Revenue Market Share by Country in 2023
Figure 55. Europe Vascular Stents Sales Market Share by Type (2019-2024)
Figure 56. Europe Vascular Stents Sales Market Share by Application (2019-2024)
Figure 57. Germany Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 58. France Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 59. UK Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 60. Italy Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 61. Russia Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 62. Middle East & Africa Vascular Stents Sales Market Share by Country in 2023
Figure 63. Middle East & Africa Vascular Stents Revenue Market Share by Country in 2023
Figure 64. Middle East & Africa Vascular Stents Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Vascular Stents Sales Market Share by Application (2019-2024)
Figure 66. Egypt Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 67. South Africa Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 68. Israel Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 69. Turkey Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 70. GCC Country Vascular Stents Revenue Growth 2019-2024 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Vascular Stents in 2023
Figure 72. Manufacturing Process Analysis of Vascular Stents
Figure 73. Industry Chain Structure of Vascular Stents
Figure 74. Channels of Distribution
Figure 75. Global Vascular Stents Sales Market Forecast by Region (2025-2030)
Figure 76. Global Vascular Stents Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Vascular Stents Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Vascular Stents Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Vascular Stents Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Vascular Stents Revenue Market Share Forecast by Application (2025-2030)

Related Tags

Related Reports

payment cards

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Kavita Mehra

Kavita Mehra

Business Development Manager

Trusted Partners

NONWOVENS_INDUSTRY
FB
issuewire
Financial_Express
logo_yourstory
FB

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

  • Order Placed (09 May, 2026)
  • Notify To Team (09 May, 2026)
  • Report updation (10 May, 2026)
  • Report Quality Check (10 May, 2026)
  • Report Dispatch (11 May, 2026)

  • paypal
  • icici
  • stripe
  • wire-transfer

  • Email
  • Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Recently Viewed Products

Logo

Global Vascular Stents Market Growth 2024-2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.

We uses Cookies

We use cookies to ensure you get the best experience on our website.